Study of H5N1 from an infected person // Assessing ways to gauge aging status // Implantable device reverses opioid overdose in animals //

Study of H5N1 from an infected person https://www.nih.gov/news-events/nih-research-matters/study-h5n1-infected-person Assessing ways to gauge aging status https://www.nih.gov/news-events/nih-research-matters/assessing-ways-gauge-aging-status Implantable device reverses opioid overdose in animals https://www.nih.gov/news-events/nih-research-matters/implantable-device-reverses-opioid-overdose-animals

Lassa fever research priorities: towards effective medical countermeasures by the end of the decade

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00229-9/abstract?utm_campaign=update-laninf&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_laninf&_hsenc=p2ANqtz-9mhlnTC_HTSIiYtRwwsznDtjmj1HVZeBF00rEU0uO8KmhlJQg_0IyX5CQ8eh43snX6sdRXzsx31CvM0jjwkxA9M2mt8g&_hsmi=332473122&utm_content=332424833&utm_source=hs_email

Comparative effectiveness of combination therapy with nirmatrelvir–ritonavir and remdesivir versus monotherapy with remdesivir or nirmatrelvir–ritonavir in patients hospitalised with COVID-19: a target trial emulation study

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00353-0/fulltext?dgcid=hubspot_update_feature_updatealerts_laninf&utm_campaign=update-laninf&utm_medium=email&_hsenc=p2ANqtz-8GFSVCrlqECfZvC8b1f_ReQCh44yTZicycvq0mdCTlbbmCxoJj9A29pzJUrhKjQAK4qN4xqD4tErVmkkGcRvRzdWNffQ&_hsmi=332473122&utm_content=332424833&utm_source=hs_email

The responsibility of publishing early outbreak data The Lancet Infectious Diseases

https://www.thelancet.com/journals/laninf/issue/vol24no11/PIIS1473-3099(24)X0011-0

Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00358-X/fulltext?dgcid=hubspot_update_feature_updatealerts_laninf&utm_campaign=update-laninf&utm_medium=email&_hsenc=p2ANqtz--Xb2xl48W91l-mFCfxnumIwg2F7iM3bqrxyjSZ3aGa84Plb2Nspoyp42F0CzFT78NvDFdFnNQTgiyXqzLenZ4yTCwCKg&_hsmi=332473122&utm_content=332424833&utm_source=hs_email

Quantitative flow ratio versus fractional flow reserve for coronary revascularisation guidance (FAVOR III Europe): a multicentre, randomised, non-inferiority trial

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)02175-5/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_tct24&_hsenc=p2ANqtz-_1Y2lM5dyWl0cVAtJQC-juVf97wdHAtmfBSDzssrzG1KX1Duxo-uglKLEwYgdXihndMGGGWZVszk8Pv2IM-gzI8FcxfA&_hsmi=331345500&utm_content=331345500&utm_source=hs_email

Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART): a single-blind, non-inferiority, registry-based, randomised controlled trial

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)02227-X/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_tct24&_hsenc=p2ANqtz-_GlkT7lzu3oHUojIHP4jZjuqISi_UVd-PsnB9mjjXKg7-NvUXNofkpgiuj6wFwbu7v4-dHX1PgCs31p98SZPaoMfFlog&_hsmi=331345500&utm_content=331345500&utm_source=hs_email